Investigation on anticancer agent against cervical and colorectal cancer cell lines: One-pot synthesis, in vitro and in silico assays of xanthone derivatives

Kurniawan, Yehezkiel Steven and Fatmasari, Nela and Pranowo, Harno Dwi and Sholikhah, Eti Nurwening and Jumina, Jumina (2024) Investigation on anticancer agent against cervical and colorectal cancer cell lines: One-pot synthesis, in vitro and in silico assays of xanthone derivatives. Journal of Applied Pharmaceutical Science, 14 (3). pp. 145-153. ISSN 22313354

[thumbnail of 255_Yehezkiel Steven Kurniawan.pdf] Text
255_Yehezkiel Steven Kurniawan.pdf - Published Version
Restricted to Registered users only
Available under License Creative Commons Attribution.

Download (1MB) | Request a copy

Abstract

Cervical or colorectal cancer disease attracts the world’s attention due to the high mortality in a year. Because of that, an effective anticancer treatment employing an active anticancer agent is urgently needed. Herein, we reported the synthesis and evaluation of the anticancer activity of hydroxylated xanthones against cervical (HeLa) and colorectal (WiDr) cancer cell lines. The hydroxylated xanthones were successfully synthesized through a one-pot reaction between hydroxybenzoic acid and phenolic derivatives in a 6.60-46.50 yield. Their chemical structures have been confirmed using Fourier-transforms infrared, nuclear magnetic resonance, and mass spectrometries. From the in vitro anticancer investigation, 1,3-dihydroxyxanthone exhibited the strongest anticancer activity against HeLa and WiDr cancer cells among the examined hydroxylated xanthones. The 1,3-dihydroxyxanthone gave half-maximal inhibitory concentration and selectivity index values of 0.086-0.114 mM and 2.690-3.591, respectively. The in silico molecular docking studies revealed that 1,3-dihydroxyxanthone interacted with Adenine12, Guanine13, Cytosine14, Arginine503, Glycine504, Lysine505, Isoleucine506, Leucine507, Asparagine520, Alanine521, and Glutamic acid522 through noncovalent forces generating the Gibbs free energy of −6.85 kcal/mol in the active site of Topoisomerase II protein receptor. These results demonstrate that 1,3-dihydroxyxanthone could act as an active anticancer agent against cervical and colorectal cancer cells by inhibiting the Topoisomerase II protein receptor. © 2024, Yehezkiel Steven Kurniawan et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License(https://creativecommons.org/licenses/by/4.0/). All rights reserved.

Item Type: Article
Additional Information: Cited by: 1; All Open Access, Gold Open Access
Uncontrolled Keywords: Anticancer; cervical; colorectal; hydroxylated xanthone; one-pot synthesis
Subjects: Q Science > QD Chemistry
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Medicine, Public Health and Nursing > Non Surgical Divisions
Depositing User: Ngesti Gandini
Date Deposited: 18 Mar 2025 06:47
Last Modified: 18 Mar 2025 06:47
URI: https://ir.lib.ugm.ac.id/id/eprint/15810

Actions (login required)

View Item
View Item